Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of METTL13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adipose | 100% | 1561.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 100% | 2113.07 | 258 / 258 | 0% | 0 | 0 / 0 |
| bladder | 100% | 1576.62 | 21 / 21 | 0% | 0 | 0 / 0 |
| breast | 100% | 1678.89 | 459 / 459 | 0% | 0 | 0 / 0 |
| esophagus | 100% | 1452.68 | 1445 / 1445 | 0% | 0 | 0 / 0 |
| kidney | 100% | 1246.75 | 89 / 89 | 0% | 0 | 0 / 0 |
| liver | 100% | 1018.54 | 226 / 226 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1464.59 | 803 / 803 | 0% | 0 | 0 / 0 |
| ovary | 100% | 1357.85 | 180 / 180 | 0% | 0 | 0 / 0 |
| prostate | 100% | 1452.98 | 245 / 245 | 0% | 0 | 0 / 0 |
| skin | 100% | 2292.21 | 1809 / 1809 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1935.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| thymus | 100% | 1449.32 | 653 / 653 | 0% | 0 | 0 / 0 |
| uterus | 100% | 1680.96 | 170 / 170 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1201.03 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 100% | 1567.31 | 965 / 966 | 0% | 0 | 0 / 0 |
| pancreas | 100% | 951.85 | 327 / 328 | 0% | 0 | 0 / 0 |
| stomach | 99% | 1338.72 | 357 / 359 | 0% | 0 | 0 / 0 |
| lung | 99% | 1423.91 | 572 / 578 | 0% | 0 | 0 / 0 |
| brain | 99% | 1171.65 | 2610 / 2642 | 0% | 0 | 0 / 0 |
| heart | 97% | 968.25 | 838 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 88% | 1237.71 | 821 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032259 | Biological process | methylation |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_1902807 | Biological process | negative regulation of cell cycle G1/S phase transition |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
| Gene name | METTL13 |
| Protein name | eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)] |
| Synonyms | EEF1AKNMT CGI-01 KIAA0859 FEAT |
| Description | FUNCTION: Dual methyltransferase that catalyzes methylation of elongation factor 1-alpha (EEF1A1 and EEF1A2) at two different positions, and is therefore involved in the regulation of mRNA translation . Via its C-terminus, methylates EEF1A1 and EEF1A2 at the N-terminal residue 'Gly-2' . Via its N-terminus dimethylates EEF1A1 and EEF1A2 at residue 'Lys-55' . Has no activity towards core histones H2A, H2B, H3 and H4 . Negatively regulates cell proliferation at G1/S transition via transcriptional suppression of cell cycle regulatory genes such as CDK4 and CDK6 . . |
| Accessions | ENST00000367737.9 [Q8N6R0-1] ENST00000362019.7 [Q8N6R0-3] ENST00000361735.4 [Q8N6R0-5] Q8N6R0 |